{"id":"https://openalex.org/W2560165063","doi":"https://doi.org/10.1161/circulationaha.116.025257","title":"Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers","display_name":"Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers","publication_year":2016,"publication_date":"2016-12-05","ids":{"openalex":"https://openalex.org/W2560165063","doi":"https://doi.org/10.1161/circulationaha.116.025257","mag":"2560165063","pmid":"https://pubmed.ncbi.nlm.nih.gov/27920076","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5145004"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.116.025257","doi":"https://doi.org/10.1161/circulationaha.116.025257","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.116.025257","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025257?download=true","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025257?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103517545","display_name":"Lori A. Gordon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori A. Gordon","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061423234","display_name":"Parag Kumar","orcid":"https://orcid.org/0000-0003-2757-8649","observed_orcids":["https://orcid.org/0000-0003-2757-8649"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Parag Kumar","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068923671","display_name":"Kristina M. Brooks","orcid":"https://orcid.org/0000-0002-3832-8699","observed_orcids":["https://orcid.org/0000-0002-3832-8699"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristina M. Brooks","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050748195","display_name":"Anela Kellogg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anela Kellogg","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085746899","display_name":"Maryellen McManus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryellen McManus","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108519886","display_name":"Raul M. Alfaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raul M. Alfaro","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110189725","display_name":"Khanh Nghiem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khanh Nghiem","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103959976","display_name":"Jomy M. George","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jomy M. George","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052704460","display_name":"Jay Nelson Lozier","orcid":"https://orcid.org/0000-0003-4074-3629","observed_orcids":["https://orcid.org/0000-0003-4074-3629"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Lozier","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019363661","display_name":"Scott R Penzak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott R. Penzak","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049246976","display_name":"Colleen M. Hadigan","orcid":"https://orcid.org/0000-0003-0642-7817","observed_orcids":["https://orcid.org/0000-0003-0642-7817"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I169251466","display_name":"Xavier University of Louisiana","ror":"https://ror.org/0085d9t86","country_code":"US","type":"education","lineage":["https://openalex.org/I169251466"]},{"id":"https://openalex.org/I2802090120","display_name":"University of North Texas System","ror":"https://ror.org/03qbxj466","country_code":"US","type":"education","lineage":["https://openalex.org/I2802090120"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Hadigan","raw_affiliation_strings":["From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","Parker Tide Corporation, Washington, DC (M.M.)","University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Clinical Pharmacokinetics Research Unit, Clinical Center Pharmacy Department, (L.A.G., R.K., K.M.B., R.M.A., J.M.G., S.R.P.), Clinical Research Center, Clinical Center Department of Laboratory Medicine (K.N., J.L.), National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD; Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.); Leidos Biomedical Research, Inc, Frederick, MD (A.K.); Parker Tide Corporation, Washington, DC (M.M","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I169251466","https://openalex.org/I4210134534","https://openalex.org/I4210155647","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Leidos Biomedical Research, Inc, Frederick, MD (A.K.)","institution_ids":["https://openalex.org/I4396570585"]},{"raw_affiliation_string":"Parker Tide Corporation, Washington, DC (M.M.)","institution_ids":[]},{"raw_affiliation_string":"University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth (S.R.P.)","institution_ids":["https://openalex.org/I2802090120"]},{"raw_affiliation_string":"Xavier University of Louisiana, College of Pharmacy, New Orleans (L.A.G.)","institution_ids":["https://openalex.org/I169251466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.2506,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.96427097,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"134","issue":"23","first_page":"1909","last_page":"1911"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.638700008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.638700008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.21619999408721924,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.04820000007748604,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cobicistat","display_name":"cobicistat","score":0.7979999780654907},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.859000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7850000262260437},{"id":"https://openalex.org/keywords/anticoagulant-activity","display_name":"anticoagulant activity","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.3269999921321869},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8330000042915344},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibition","display_name":"P-glycoprotein inhibition","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8510000109672546},{"id":"https://openalex.org/keywords/idarucizumab","display_name":"idarucizumab","score":0.7960000038146973},{"id":"https://openalex.org/keywords/thromboembolism","display_name":"thromboembolism","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8115878105163574},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4777897298336029},{"id":"https://openalex.org/C2780524789","wikidata":"https://www.wikidata.org/wiki/Q5138908","display_name":"Cobicistat","level":5,"score":0.44629061222076416},{"id":"https://openalex.org/C10446079","wikidata":"https://www.wikidata.org/wiki/Q155491","display_name":"Clinical pharmacy","level":3,"score":0.43033671379089355},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.4286121726036072},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3540002703666687},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.28271710872650146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27397167682647705},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.1880245804786682},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1702195703983307},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.15555766224861145},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.08018931746482849}],"mesh":[{"descriptor_ui":"D000069547","descriptor_name":"Cobicistat","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069547","descriptor_name":"Cobicistat","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013918","descriptor_name":"Thrombin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1161/circulationaha.116.025257","doi":"https://doi.org/10.1161/circulationaha.116.025257","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.116.025257","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025257?download=true","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:27920076","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27920076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"},{"id":"pmh:oai:europepmc.org:4628028","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5145004","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5145004","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5145004","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Circulation","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1161/circulationaha.116.025257","doi":"https://doi.org/10.1161/circulationaha.116.025257","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.116.025257","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025257?download=true","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G244708199","display_name":"The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Phar","funder_award_id":"ZIACL006005","funder_id":"https://openalex.org/F4320337376","funder_display_name":"NIH Clinical Center"},{"id":"https://openalex.org/G3814049862","display_name":"Xavier RCMI Center for Cancer Research ","funder_award_id":"G12MD007595","funder_id":"https://openalex.org/F4320337534","funder_display_name":"National Institute on Minority Health and Health Disparities"},{"id":"https://openalex.org/G550647324","display_name":null,"funder_award_id":"Z99CL999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8838525055","display_name":null,"funder_award_id":"Z99 AI999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337376","display_name":"NIH Clinical Center","ror":"https://ror.org/04vfsmv21"},{"id":"https://openalex.org/F4320337534","display_name":"National Institute on Minority Health and Health Disparities","ror":"https://ror.org/0493hgw16"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2560165063.pdf","grobid_xml":"https://content.openalex.org/works/W2560165063.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W165837497","https://openalex.org/W1558500336","https://openalex.org/W2262565322","https://openalex.org/W2275789744","https://openalex.org/W2294678755"],"related_works":["https://openalex.org/W2745713480","https://openalex.org/W7208779408","https://openalex.org/W2933334053","https://openalex.org/W2938196622","https://openalex.org/W2593285831","https://openalex.org/W2557368926","https://openalex.org/W4403369629","https://openalex.org/W2400638052","https://openalex.org/W7038592068","https://openalex.org/W2398034404"],"abstract_inverted_index":{"rug":[0],"interactions":[1],"between":[2],"antiretroviral":[3,145,172],"therapy":[4],"and":[5,33,75,95,121,124,187,189,208,247,258,303,333,355,385,392,424],"anticoagulant":[6,66,81,209],"medications":[7],"are":[8,167],"of":[9,15,23,109,118,148,157,184,202,211,256,269,293,312,382,396],"particular":[10],"concern":[11],"given":[12,296,315],"that":[13,138],"\u224850%":[14],"the":[16,52,62,69,77,164,200,205,248,253,361,383,414],"current":[17],"HIV":[18,25,162],"population":[19,54],"is":[20,27,76,102,115,128,139,180],">50":[21],"years":[22],"age.Moreover,":[24],"infection":[26],"characterized":[28],"by":[29,68,252,371],"a":[30,83,104,116,129,170,266,276,289,308,409],"hypercoaguable":[31],"state":[32],"premature":[34],"immunologic":[35],"aging,":[36],"in":[37,51,163,230,401,404,412],"which":[38],"thromboembolic":[39],"events":[40],"may":[41],"be":[42],"as":[43,45],"much":[44],"10":[46],"times":[47],"more":[48],"prevalent":[49],"than":[50],"general":[53],"across":[55],"all":[56,158,380],"age":[57],"spectra.":[58],"1":[59,305,391],"Dabigatran":[60],"was":[61,228,250,295,314,325],"first":[63,264],"direct":[64,79,98],"oral":[65,80,99],"approved":[67,251],"US":[70,84,130],"Food":[71,85,131],"&":[72,86,132],"Drug":[73,87,133],"Administration":[74,88,134],"only":[78],"with":[82,141,161,317,363,408],"-approved":[89,135],"specific":[90],"reversal":[91],"agent,":[92],"idarucizumab.Unlike":[93],"warfarin":[94],"many":[96],"other":[97],"anticoagulants,":[100],"dabigatran":[101,114,212,270,294,313,322,405],"not":[103],"substrate,":[105],"inhibitor,":[106],"or":[107],"inducer":[108],"cytochrome":[110,153,176],"P450":[111,154,177],"metabolic":[112],"enzymes.However,":[113],"substrate":[117],"Permeability-glycoprotein":[119],"(P-gp)":[120],"renal":[122],"multidrug":[123,188],"toxin":[125,190],"extrusion-1":[126,191],"transporters.Cobicistat":[127],"antiretroviralboosting":[136],"agent":[137],"coformulated":[140],"numerous":[142],"fixed-dose":[143],"combination":[144],"products":[146],"because":[147],"its":[149],"inhibitory":[150],"effects":[151,210],"on":[152,169],"3A4.Currently,":[155],"\u224840%":[156],"treatment-na\u00efve":[159],"patients":[160],"United":[165],"States":[166],"initiated":[168],"cobicistat-boosted":[171],"regimen.In":[173],"addition":[174],"to":[175,197,349,422],"3A4,":[178],"cobicistat":[179,203,283,300,318,397],"also":[181],"an":[182,386],"inhibitor":[183],"both":[185,413],"P-gp":[186],"transporters.2":[192],"Thus,":[193],"this":[194,221],"study":[195,227,249],"aimed":[196],"determine":[198],"whether":[199,216],"coadministration":[201],"increases":[204,403],"systemic":[206],"exposure":[207],"and,":[213],"if":[214],"so,":[215],"separating":[217],"administration":[218,395],"would":[219],"circumvent":[220],"interaction.This":[222],"open-label,":[223],"single-sequence":[224],"drug":[225],"interaction":[226],"conducted":[229],"healthy":[231],"HIV-negative":[232],"volunteers":[233],"(Clinical":[234],"Trial":[235],"Registration:":[236],"URL:":[237],"https://www.clinicaltrials.gov,":[238],"Unique":[239],"identifier:":[240],"NCT01896622).All":[241],"participants":[242,280,378],"gave":[243],"written":[244],"informed":[245],"consent,":[246],"National":[254],"Institute":[255],"Allergy":[257],"Infectious":[259],"Diseases":[260],"Institutional":[261],"Review":[262],"Board.Participants":[263],"received":[265],"single":[267,291,310],"dose":[268,292,311,362],"150":[271,284],"mg":[272,285],"alone":[273],"(Phase":[274,301,319,398],"1).After":[275],"5-day":[277],"washout":[278],"period,":[279],"then":[281,304],"began":[282],"daily.After":[286],"2":[287,297,388,393],"weeks,":[288],"second":[290],"hours":[298,330,359],"before":[299],"2),":[302],"week":[306],"later,":[307],"third":[309],"simultaneously":[316],"3).After":[320],"each":[321],"dose,":[323],"blood":[324],"collected":[326],"serially":[327],"over":[328],"24":[329,358],"for":[331],"pharmacokinetic":[332,406],"thrombin":[334],"time":[335,347,420],"(TT)":[336],"analysis":[337],"(STA-Thrombin":[338],"assay,":[339],"Diagnostica":[340],"Stago,":[341],"Inc.),":[342],"including":[343],"area-under-the-concentration-versus-time":[344,417],"curve":[345,418],"from":[346,419],"zero":[348,421],"infinity,":[350],"maximal":[351,425],"concentration,":[352],"area-under-the-TT-effect-versus-time":[353],"curve,":[354],"TT":[356],"at":[357],"after":[360],"Phoenix":[364],"WinNonlin":[365],"software":[366],"(v6.4).P":[367],"values":[368],"were":[369],"calculated":[370],"paired":[372],"Student":[373],"t":[374],"tests":[375],"(Microsoft":[376],"Excel).Sixteen":[377],"completed":[379,389],"phases":[381],"study,":[384],"additional":[387],"Phases":[390],"only.Simultaneous":[394],"3)":[399],"resulted":[400],"significant":[402],"exposure,":[407],"127%":[410],"increase":[411],"geometric":[415],"mean":[416],"infinity":[423],"concentration":[426],"(P<0.001).Although":[427],"no":[428],"altera-":[429]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-12-16T00:00:00"}